Protein synthesis machinery (Entamoeba histolytica)

The protein synthesis machinery of Entamoeba histolytica is a complex system responsible for translating genetic information into functional proteins, which is essential for the parasite's survival, growth, and virulence (PubMed: 25605773). It primarily consists of the 80S ribosome, composed of 40S and 60S subunits, along with various translation factors and aminoacyl-tRNA synthetases. This machinery is a critical therapeutic target for treating amoebiasis, as certain antibiotics can selectively bind to the parasite's ribosomal components to inhibit protein production (CDC: Amoebiasis). For instance, paromomycin, an aminoglycoside, targets the small ribosomal subunit to induce mRNA misreading and halt translation (PubChem: Paromomycin). While effective, the high degree of conservation in translation components across eukaryotes necessitates the identification of parasite-specific structural features to minimize host toxicity. Understanding these molecular differences is vital for developing next-generation anti-amoebic agents that overcome resistance and reduce side effects (PubMed: 30254014). The machinery also includes unique elongation factors and tRNA synthetases that are being explored as potential niche targets for drug development.

Other names

Entamoeba histolytica ribosomeTranslation machinery80S ribosome (Entamoeba histolytica)Ribosomal complex

Inhibition of protein synthesis by binding to ribosomal subunits (primarily the 40S subunit), leading to mRNA misreading and premature termination of peptide chain synthesis (PubChem: Paromomycin).